FeesSafety
Pluang+

Chemomab advances merger with Scipher, plans Phase 2 trial for rheumatoid arthritis drug nebokitug in early 2027

Company Fundamentals
19 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Chemomab advances merger with Scipher, plans Phase 2 trial for rheumatoid arthritis drug nebokitug in early 2027

Chemomab Therapeutics announced progress in its proposed merger with Scipher Medicine, with SEC approval of the merger registration and a shareholder vote scheduled for December 4, 2026. The merger aims to combine Chemomab's anti-CCL24 antibody nebokitug with Scipher's precision medicine platform to develop treatments for rheumatoid arthritis (RA), a market valued at $24 billion annually. Following FDA feedback on their Phase 2 trial plans, the companies expect to initiate the trial in the first half of 2027 and report topline results by mid-2028. The merger is expected to close in Q1 2027, creating a combined company focused on immunology precision medicine.

Chemomab Therapeutics' third quarter 2026 financial results and merger update provide context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 19, 2026 19:13 WIB: Out of 150 priced health-sector US stocks, 82 rose and 63 fell. Among notable movers, Elanco Animal Health (ELAN) rose 2.92% to USD 27.48 with a typical hold time of 20 days, Erasca Inc. (ERAS) increased 2.76% to USD 14.14 with a typical hold time of 4 days, and Sana Biotechnology (SANA) gained 2.70% to USD 1.90 despite a 60% sell order activity and a longer typical hold time of 27 days.

More News

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works reported third-quarter earnings per share of $0.26, surpassing the $0.12 estimate, and revenue of $1.58 billion, above the $1.55 billion estimate. The company also announced a new $500 million share repurchase program and raised its...

Company Fundamentals
Bullish
52 minutes ago
Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal has integrated its neutral-atom quantum processors natively into Slurm's Hierarchical Resources (HRES) system, recently expanded by NVIDIA. This allows supercomputing centers to manage quantum processing units (QPUs) alongside CPUs and GPUs mo...

Market News
Bullish
56 minutes ago
SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX currently earns most of its profits from its Starlink satellite internet service, which has 13.6 million subscribers and generated $2.37 billion in operating income last quarter. However, the company is aggressively pivoting towards artificial...

Market News
Bullish
1 hour ago
TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

Despite a recent 25% drop in semiconductor stocks, TSMC and Applied Materials stand out due to their dominant market positions and growth potential. TSMC leads with a 73% share in the foundry market, benefiting from AI chip demand and planned price h...

Market News
Bullish
1 hour ago
Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

The stock market is vulnerable to a sharp correction due to rising interest rates and uncertainty in the AI industry following Nvidia CEO Jensen Huang's departure amid scandal. Inflation pressures have led the Federal Reserve to raise rates, potentia...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App